Yamamoto Kazuya, Noda Takumi, Ito Koichi, Miura Hiroyuki, Murata Makoto, Yokota Chiaki
Department of Stroke and Cardiovascular Rehabilitation, National Cerebral and Cardiovascular Center, Japan.
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.
Phys Ther Res. 2025;28(2):99-105. doi: 10.1298/ptr.E10322. Epub 2025 May 9.
Inpatient cardiac rehabilitation (CR) and pharmacotherapy are important for better in-hospital outcomes in elderly heart failure (HF) patients. We aimed to examine whether conventional CR combined with Waon therapy (Waon-CR) improves exercise capacity compared to CR alone in elderly HF patients.
Decompensated and hospitalized HF patients who could not walk independently over 200 m were recruited. Patients admitted from May 2020 to March 2021 and from April 2021 to March 2024 were included in the CR and Waon-CR groups, respectively. Participants underwent a 5-session program during hospitalization. The main outcome measure was a 6-minute walk distance (6MWD) at the completion of the program. We also investigated exercise-related adverse events.
A total of 34 patients (mean age 79.5 years, 13 males) were enrolled, including 18 patients in the CR group and 16 patients in the Waon-CR group. The 6MWD after the 5-session program was longer in the Waon-CR group than in the CR group (362.2 ± 103.7 vs. 286.3 ± 100.6 m, p = 0.038). Significant improvement of the 6MWD was demonstrated in the Waon-CR group after adjusting for confounding factors (adjusted B, 147.0 m; 95% confidence interval, 41.3-252.8 m, p = 0.012). There were no adverse events during the hospital stay.
Inpatient Waon-CR was feasible and led to improved 6MWD in elderly HF patients at the completion of the 5-session program.
住院心脏康复(CR)和药物治疗对于改善老年心力衰竭(HF)患者的院内结局很重要。我们旨在研究在老年HF患者中,与单纯CR相比,传统CR联合温热疗法(Waon-CR)是否能提高运动能力。
招募无法独立行走超过200米的失代偿期住院HF患者。分别将2020年5月至2021年3月以及2021年4月至2024年3月收治的患者纳入CR组和Waon-CR组。参与者在住院期间接受了一个为期5节的项目。主要结局指标是项目结束时的6分钟步行距离(6MWD)。我们还调查了与运动相关的不良事件。
共纳入34例患者(平均年龄79.5岁,男性13例),其中CR组18例,Waon-CR组16例。Waon-CR组在5节项目后的6MWD比CR组长(362.2±103.7米对286.3±100.6米,p = 0.038)。在调整混杂因素后,Waon-CR组的6MWD有显著改善(调整后的B值为147.0米;95%置信区间为41.3 - 252.8米,p = 0.012)。住院期间未发生不良事件。
住院Waon-CR是可行的,并且在5节项目结束时能改善老年HF患者的6MWD。